Human Lysine Demethylase JMJD2D (KDM4D); A Target Enabling Package
Description
The work at the SGC has been supported by the Innovative Medicines Initiative Joint Undertaking (IMI JU) under grant agreement [115766]. This document represents version 4 of the TEP datasheet and includes all updates on the project as of June 2018. For more information about TEPs and the TEP Programme, please visit https://thesgc.org/tep.
Resources
| Name |
Format |
Description |
Link |
|
0 |
|
http://data.europa.eu/88u/dataset/oai-zenodo-org-1287265 |
|
0 |
|
http://data.europa.eu/88u/dataset/oai-zenodo-org-1287265 |
|
0 |
|
http://data.europa.eu/88u/dataset/oai-zenodo-org-1287265 |
Tags
- neuropsychiatry
- jmjd2d
- disease
- neurological-genetic-disorders
- structural-genomics
- target-enabling-package
- metabolic-diseases
- structure
- malaria
- structure-discovery
- drug-target
- protein
- chemical-probe
- orphan-disease
- chemical-biology
- cancer
- drug-discovery
- kdm4d
- infectious-disease
- neuro
- genetics